OxDX combines single-molecule fluorescent microscopy with machine learning to produce rapid pathogen detection tests that can recognize specific strains within seconds. The company uses a universal labeling system to illuminate everything in a sample, images the sample with super-resolution fluorescence microscopy, and analyzes the images with a neural network. OxDX's stated goal is to enable clinicians to ask broadly open questions about the causes of infection by providing fast, detailed diagnostics. The company is a University of Oxford spin-out based in Oxford, UK. OxDX plans to use the new funding to expand its team and further validate the technology with development partners. No operating metrics were reported in the article.

Total raised

$4M

Funding rounds

1

Latest round

Seed

Latest activity

Feb 2022